V
Veracyte, Inc.
VCYT · NASDAQ · Healthcare · 3.3B
Closing price
$45.23
+3.74% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
53.6×
Price / net assetsP/B
2.7×
Enterprise value / EBITDAEV/EBITDA
36.1×
Free cash flow yieldFCF yield
3.6%
Return on equityROE
5.1%
Operating margin
14.3%
Net debt / EBITDAbalance-sheet strength
-3.6×
Interest coverage
—
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.